Last update:

Neuroscience news

Neuroscience

The basis of voluntary movements: Monkey study challenges classical views on how brain controls natural actions

A study published in Science reveals new mechanisms through which the brain controls natural actions. The results challenge some of the classical views about how the motor system works and open up possible new applications ...

Psychology & Psychiatry

High-fat diet during adolescence increases impulsive behaviors in adult rodents

For adults, a diet high in saturated fats and added sugar has been linked to impulsivity and poor self-control. But what role, if any, does diet play in adolescent psychological development?

Neuroscience

What is the average wait time to see a neurologist?

Older people wait an average of just over a month to see a neurologist for specialty care after being referred by their primary care physician or another physician, according to a study published in the January 8, 2025, online ...

Neuroscience

New coating extends lifespan of neural implants in the body

Neural implants contain integrated circuits (ICs)—commonly called chips—built on silicon. These implants need to be small and flexible to mimic circumstances inside the human body. However, the environment within the ...

Neuroscience

Study highlights need for non-motor care in stroke recovery

Care for stroke survivors urgently needs to focus on non-motor skill outcomes such as fatigue, anxiety and reduced social participation to improve survivors' quality of life and minimize care needs, according to a new study ...

Genetics

Study shows potential of optogenetics in treating epilepsy

In what could one day become a new treatment for epilepsy, researchers at UC San Francisco, UC Santa Cruz and UC Berkeley have used pulses of light to prevent seizure-like activity in neurons.The study appears Nov. 15 in ...

Medications

FDA approves Cobenfy for adults with schizophrenia

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.

Neuroscience

Indicators of an aging brain: A 20-year study

Johns Hopkins University-led researchers, working with the Biomarkers for Older Controls at Risk for Dementia (BIOCARD) cohort, have found that certain factors are linked to faster brain shrinkage and quicker progression ...